2024-04-19 01:07 | CC:PTN | Proton Capital Corp | | SEDAR MD & A815 | SEDAR MD & A |
2024-04-19 01:06 | CC:PTN | Proton Capital Corp | | SEDAR Audited Annual Financial Statements804 | SEDAR Audited Annual Financial Statements |
2024-03-22 09:56 | CC:PTN | Proton Capital Corp | | News Release200 | Proton Capital files preliminary long form prospectus |
2024-03-20 16:01 | CC:PTN | Proton Capital Corp | | SEDAR Preliminary Long Form Prospectus817 | SEDAR Preliminary Long Form Prospectus |
2024-02-22 00:42 | CC:PTN | Proton Capital Corp | | News Release200 | Proton Capital to acquire 75% of target pharmacy as QT |
2024-01-22 17:29 | CC:PTN | Proton Capital Corp | | News Release200 | Proton Capital still working on QT definitive deal |
2023-11-09 15:34 | CC:PTN | Proton Capital Corp | | SEDAR Interim MD & A813 | SEDAR Interim MD & A |
2023-11-09 15:32 | CC:PTN | Proton Capital Corp | | SEDAR Interim Financial Statements812 | SEDAR Interim Financial Statements |
2023-10-10 15:04 | CC:PTN | Proton Capital Corp | 0.21 | News Release200 | Proton Capital arranges $40-million public offering |
2023-08-31 15:29 | CC:PTN | Proton Capital Corp | 0.21 | News Release200 | Proton Capital signs licence deal with PharmaChoice |
2023-08-17 17:18 | CC:PTN | Proton Capital Corp | 0.21 | SEDAR Interim MD & A813 | SEDAR Interim MD & A |
2023-08-17 17:16 | CC:PTN | Proton Capital Corp | 0.21 | SEDAR Interim Financial Statements812 | SEDAR Interim Financial Statements |
2023-07-26 15:21 | CC:PTN | Proton Capital Corp | 0.21 | News Release200 | Proton Capital still in talks with PharmaChoice |
2023-05-26 16:12 | CC:PTN | Proton Capital Corp | 0.21 | SEDAR Interim Financial Statements812 | SEDAR Interim Financial Statements |
2023-05-26 16:12 | CC:PTN | Proton Capital Corp | 0.21 | SEDAR MD & A815 | SEDAR MD & A |